Neurosurgical procedures

Use of ViviGen® Cellular Bone Matrix results in significantly lower hospital costs compared to rhBMP-2

Retrieved on: 
Monday, November 23, 2020
Branches of biology, Medical specialties, Clinical medicine, Growth factors, Bone morphogenetic protein, Proteins, Skeletal system, Neurosurgical procedures, Transplantation medicine, Spinal fusion, Bone, Medication-related osteonecrosis of the jaw

VIRGINIA BEACH, Va., Nov. 23, 2020 /PRNewswire/ -- ViviGen Cellular Bone Matrix is associated with significantly lower hospital costs compared torecombinant human bone morphogenetic protein-2 (rhBMP-2), according to an analysis of more than 16,000 U.S. lumbar fusions procedures.

Key Points: 
  • VIRGINIA BEACH, Va., Nov. 23, 2020 /PRNewswire/ -- ViviGen Cellular Bone Matrix is associated with significantly lower hospital costs compared torecombinant human bone morphogenetic protein-2 (rhBMP-2), according to an analysis of more than 16,000 U.S. lumbar fusions procedures.
  • The data shows that ViviGen provides hospitals with a fusion solution that is more cost effective than rhBMP-2.
  • "These results emphasize the true economic advantages it offers as well, bringing together successful outcomes and drastically lower costs."
  • ViviGen is the first cellular allograft to focus on recovering and protecting viable, lineage-committed bone cells to support the bone-healing process.

NuVasive Expands Proprietary Porous PEEK Portfolio with Cohere XLIF Interbody

Retrieved on: 
Wednesday, November 18, 2020
Medical specialties, Surgery, Clinical medicine, Neurosurgical procedures, Anterior cervical discectomy and fusion, NuVasive, Spinal fusion, Polyether ether ketone, Peek, Discectomy

Cohere XLIF is a key addition to NuVasive's Advanced Materials Science (AMS) implant portfolio, consisting of proprietary surface and structural technologies, and is designed for bone in-growth while maintaining the imaging and mechanical properties favored in smooth PEEK and titanium coated PEEK interbody devices.

Key Points: 
  • Cohere XLIF is a key addition to NuVasive's Advanced Materials Science (AMS) implant portfolio, consisting of proprietary surface and structural technologies, and is designed for bone in-growth while maintaining the imaging and mechanical properties favored in smooth PEEK and titanium coated PEEK interbody devices.
  • "Combined with Cohere XLIF, the Cohere XLIF AMS plate equips surgeons with additional technology when pathologic features call for it and gives confidence in a patient's path to returning to normal activities."
  • The Porous PEEK technology in Cohere XLIF has been recently studied head to head in cervical spine fusion against smooth PEEK and structural allograft bone.
  • Early clinical outcomes comparing porous PEEK, smooth PEEK, and structural allograft interbody devices for anterior cervical discectomy and fusion.

Medtronic Receives Health Canada Licence for the First-of-Its-Kind Percept™ PC Neurostimulator with Brainsense™ Technology

Retrieved on: 
Thursday, October 29, 2020
Medicine, Branches of biology, Clinical medicine, Neurotechnology, Electrotherapy, Medical devices, Neurosurgical procedures, Deep brain stimulation, Tourette syndrome, Neurostimulation, DBS, Medtronic

Next-Generation Technology Makes Perceptthe First and Only DBS System with Ability to Capture Patient-Specific Brain Signalsfor More Personalized, Data-Driven Treatment

Key Points: 
  • Next-Generation Technology Makes Perceptthe First and Only DBS System with Ability to Capture Patient-Specific Brain Signalsfor More Personalized, Data-Driven Treatment
    BRAMPTON, ON, Oct. 29, 2020 /CNW/ - Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) the world's largest medical technology, services, and solutions companies announced today that it has received a Health Canada licence forthe Percept PC Deep Brain Stimulation (DBS) system with BrainSense Technology.
  • The first implant of the newly licensed device in Canada will occur at Toronto Western Hospital.
  • In addition to BrainSense technology, the Percept PC DBS system features several leading-edge innovations, including:
    The only DBS system eligible for 3T and 1.5T full-body MRI scans, providing patients access to cutting-edge medical imaging.
  • For further information on the Percept PC Neurostimulator with BrainSense Technology, please visit: Medtronic.ca/Percept
    DBS therapy is currently licensed in many locations around the world, including the United States, Europe and Canada, for the treatment Parkinson's disease, essential tremor, dystonia, and epilepsy.

Global Deep Brain Stimulation Devices Pipeline Insight and Competitive Landscape 2020 Featuring 20 Companies & 23 Pipeline devices - ResearchAndMarkets.com

Retrieved on: 
Monday, October 12, 2020
Health, Medical devices, Other Health, Branches of biology, Medicine, Clinical medicine, Electrotherapy, Medical devices, Neurosurgical procedures, Deep brain stimulation, Tourette syndrome, DBS, Brain stimulation, Brain stimulation

The "Deep Brain Stimulation Devices Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Deep Brain Stimulation Devices Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The Deep Brain Stimulation Devices - Pipeline Insight and Competitive Landscape, 2020, report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the deep brain stimulation (DBS) devices pipeline landscape.
  • This reports provides a detailed study of the emerging DBS devices along with competitive landscape to help better understand the emerging DBS devices.
  • At present, Aleva is the only emerging technology company to be awarded the CE-Mark for Deep Brain Stimulation.

Deep Brain Stimulation (DBS) Systems Market Worth USD 2,122.8 Million By 2027 | Emergen Research

Retrieved on: 
Wednesday, September 16, 2020
Medicine, Clinical medicine, Neurotechnology, Academic journals, Electrotherapy, Medical devices, Neurosurgical procedures, Brain stimulation, Brain stimulation, Deep brain stimulation, DBS

VANCOUVER, B.C., Sept. 15, 2020 /PRNewswire/ --The global Deep Brain Stimulation (DBS) Systems Market was valued at USD 1227.5 million in 2019 and is expected to reach USD 2,122.8 million by 2027, growing at a CAGR of 8.1% according to a new report by Emergen Research.

Key Points: 
  • VANCOUVER, B.C., Sept. 15, 2020 /PRNewswire/ --The global Deep Brain Stimulation (DBS) Systems Market was valued at USD 1227.5 million in 2019 and is expected to reach USD 2,122.8 million by 2027, growing at a CAGR of 8.1% according to a new report by Emergen Research.
  • High prevalence of such diseases among elderly coupled with rising geriatric population are fuelling up the demand for the deep brain stimulation systems worldwide.
  • The systems directed in deep brain stimulation safeguards minimal damage to the surrounding brain tissues.
  • To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/deep-brain-stimulation-s...
    Emergen Research have segmented Deep Brain Stimulation (DBS) Systems Market on the basis of product, application, end use and region:
    Product Outlook (Revenue in Million USD; 20172027)
    Application Outlook (Revenue in Million USD; 20172027)

Deep Brain Stimulation (DBS) Systems Market Worth USD 2,122.8 Million By 2027 | Emergen Research

Retrieved on: 
Wednesday, September 16, 2020
Medicine, Clinical medicine, Neuroscience, Neurotechnology, Electrotherapy, Medical devices, Neurosurgical procedures, Deep brain stimulation, Tourette syndrome, Brain stimulation, Obsessive–compulsive disorder, Brain stimulation

High prevalence of such diseases among elderly coupled with rising geriatric population are fuelling up the demand for the deep brain stimulation systems worldwide.

Key Points: 
  • High prevalence of such diseases among elderly coupled with rising geriatric population are fuelling up the demand for the deep brain stimulation systems worldwide.
  • In addition, increasing incidences associated with depression, essential tremor and obsessive compulsive disorder (OCD) are further multiplying the demand of deep brain stimulation systems in the industry.
  • The systems directed in deep brain stimulation safeguards minimal damage to the surrounding brain tissues.
  • To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/deep-brain-stimulation-s...
    Emergen Research have segmented Deep Brain Stimulation (DBS) Systems Market on the basis of product, application, end use and region:
    Product Outlook (Revenue in Million USD; 20172027)
    Application Outlook (Revenue in Million USD; 20172027)

Xtant Medical Announces U.S. Commercial Launch of the Matriform® Si for Spinal Fusion Procedures

Retrieved on: 
Monday, August 24, 2020
Medical specialties, Surgery, Clinical medicine, Biomaterials, Neurosurgical procedures, Bone grafting, Oral and maxillofacial surgery, Transplantation medicine, Bioglass 45S5, Spinal fusion, Orthopedic surgery

BELGRADE, Mont., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the U.S. commercial launch of the Matriform Si, a silicated synthetic bone graft strip designed and cleared for spinal fusion procedures.

Key Points: 
  • BELGRADE, Mont., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the U.S. commercial launch of the Matriform Si, a silicated synthetic bone graft strip designed and cleared for spinal fusion procedures.
  • We are excited to launch Matriform Si in the U.S., which expands our biologics portfolio offering and increases our footprint in the U.S. orthopedic Bone Graft Substitute market, said Kevin Brandt, Chief Commercial Officer of Xtant Medical.
  • This innovative synthetic is an ultraporous, interconnected structure that is designed to enhance new bone formation and mechanical stability while preventing premature dissolution for spinal fusion procedures.
  • Comprised of 96% pure phase -TCP granules and 4% bioglass, Matriform Si is designed to provide the ideal biomimetic scaffold for spinal fusion procedures.

Deep Brain Stimulation In Parkinson's Disease Market Worth $1.42 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Monday, August 3, 2020
Medicine, Clinical medicine, Medical specialties, Neurotechnology, Neurosurgical procedures, Electrotherapy, Medical devices, Parkinson's disease, Deep brain stimulation, Levodopa-induced dyskinesia, Parkinson's disease clinical research

Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Key Points: 
  • Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.
  • Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy.
  • Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.
  • Grand View Research has segmented the global DBS in Parkinson's disease market on the basis of product, end use, and region:
    DBS In Parkinson's Disease Product Outlook (Revenue, USD Million, 2016 - 2028)
    DBS In Parkinson's Disease End-use Outlook (Revenue, USD Million, 2016 - 2028)

Deep Brain Stimulation In Parkinson's Disease Market Worth $1.42 Billion By 2028: Grand View Research, Inc.

Retrieved on: 
Monday, August 3, 2020
Medicine, Clinical medicine, Medical specialties, Neurotechnology, Neurosurgical procedures, Electrotherapy, Medical devices, Parkinson's disease, Deep brain stimulation, Levodopa-induced dyskinesia, Parkinson's disease clinical research

Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Key Points: 
  • Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.
  • Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy.
  • Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.
  • Grand View Research has segmented the global DBS in Parkinson's disease market on the basis of product, end use, and region:
    DBS In Parkinson's Disease Product Outlook (Revenue, USD Million, 2016 - 2028)
    DBS In Parkinson's Disease End-use Outlook (Revenue, USD Million, 2016 - 2028)

Spinal Elements® Announces FDA Clearance of Sapphire® X Anterior Cervical Fixation System

Retrieved on: 
Thursday, July 2, 2020
FDA, Surgery, Medical devices, Health, Radiology, Medical specialties, Surgery, Surgical specialties, Spine, Neurosurgical procedures, Spinal cord disorders, Neurosurgery

Spinal Elements, a Carlsbad, CA-based medical device company focused on spine surgery procedures, today announced the FDA clearance of Sapphire X for anterior cervical fixation.

Key Points: 
  • Spinal Elements, a Carlsbad, CA-based medical device company focused on spine surgery procedures, today announced the FDA clearance of Sapphire X for anterior cervical fixation.
  • Sapphire X is the newest product in its MIS Ultra suite of products aimed at minimizing the unintended consequences of traditional spine surgery.
  • View the full release here: https://www.businesswire.com/news/home/20200702005080/en/
    Spinal Elements Announces FDA Clearance of Sapphire X Anterior Cervical Fixation System (Photo: Business Wire)
    The Sapphire X Anterior Cervical Fixation System features unique integrated instrumentation and high angulation screws designed to help surgeons perform the procedure while preserving the patients skeletal and muscle tissue.
  • Spinal Elements has built a reputation delivering innovative and differentiated technologies that enable fundamental shifts in solutions for spine surgery.